“…In such a scenario, the expected phenotypes of excess or reduced Pax6 levels will include enhanced or reduced adhesion of r3/r5 cells, their segregation or spreading, respectively, and prevention of sharp segmental borders and boundary cell formation, as we indeed demonstrated. Pax6 regulates adhesion molecules in the CNS, such as L1, tenascin and cadherins (Duparc et al, 2006;Osumi, 2001;Osumi et al, 2008;Stoykova et al, 1997;Takahashi and Osumi, 2011;Tyas et al, 2003). As some of these adhesion molecules are expressed in the hindbrain (Liu et al, 2001;Numayama-Tsuruta et al, 2010;Takahashi and Osumi, 2008), it would be of interest to test whether Pax6 controls their expression at early stages.…”